News|Articles|October 30, 2025

Here's what you missed at the The Menopause Society’s 2025 Annual Meeting

Fact checked by: Celeste Krewson, Assistant Editor

Research at The Menopause Society 2025 meeting highlighted safety, education, and individualized care in menopause management.

At The Menopause Society’s 2025 Annual Meeting, held October 21–25 in Orlando, Florida, clinicians and researchers presented new findings on hormone therapy, nonhormonal treatments, vulvar health, and clinical practice patterns in menopause care. Key presentations emphasized individualized treatment approaches, the importance of education across specialties, and the continued need for evidence-based strategies to optimize women’s health through midlife and beyond.

Related to this article

October 10th, 2026

Well-woman visit upgrade, post-miscarriage ultrasound findings, cardio-obstetrics framework

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

October 8th, 2026

Wen Shen, MD, on steering patients to evidence-based menopause care

Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.

October 7th, 2026

Wen Shen, MD, on screening red flags during perimenopause care

Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.

October 2nd, 2026

Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care

Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.

October 1st, 2026

IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4

Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.

September 30th, 2026

Wen Shen, MD, on recognizing perimenopause as a window for healthy aging

Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.

September 23rd, 2026

Menopause proteomic scores associated with cognitive aging, dementia risk

Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.

October 9th, 2026

Real-world data link fezolinetant to fewer nighttime awakenings

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.